Section Arrow
IMTX.NASDAQ
- Immatics NV
Quotes are at least 15-min delayed:2026/04/22 09:46 EDT
Regular Hours
Last
 11.15
-0.03 (-0.27%)
Day High 
11.3 
Prev. Close
11.18 
1-M High
11.3 
Volume 
11.28K 
Bid
11.1
Ask
11.2
Day Low
11.15 
Open
11.3 
1-M Low
9.13 
Market Cap 
1.50B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.89 
20-SMA 10.35 
50-SMA 10.11 
52-W High 12.41 
52-W Low 3.94 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.61/--
Enterprise Value
1.51B
Balance Sheet
Book Value Per Share
4.24
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
48.27M
Operating Revenue Per Share
0.69
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ACRVAcrivon Therapeutics1.83+0.07+3.98%-- 
CUECue Biopharma0.54-0.13-19.40%-- 
OCGNOcugen1.72-0.05-2.82%-- 
OTLKOutlook Therapeutics0.2977-0.0217-6.79%-- 
ASBPAspire Biopharma Holdings Inc.0.2105+0.0137+6.96%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.